Skip to main content

Table 4 The levels of glucose, total and indirect bilirubin (TBIL & IBIL) as well as the activities of aspartate and alanine aminotransferases (ASAT & ALAT) in serum of the control rats and those orally administrated PZA alone, NGN 1 h prior to PZA, and NGN alone, every day for 7, 14, 21 & 28 days. Data are displayed as mean (of 5 rats) ± standard error of mean

From: The protective effect of naringenin against pyrazinamide-induced hepatotoxicity in male Wistar rats

Parameter

Time

(days)

Experimental group

Treatment effect

Control

PZA

PZA + NGN

NGN

Glucose

(mg dL−1)

7

120.20 ± 1.54a

118.70 ± 2.64a

119.54 ± 0.42a

118.40 ± 2.67a

F3, 16 = 0.161, P = 0.921

14

120.24 ± 1.13a

120.70 ± 1.44a

120.28 ± 1.00a

120.02 ± 0.92a

F3, 16 = 0.062, P = 0.979

21

121.58 ± 0.91a

127.30 ± 1.62b*

121.98 ± 0.91a

121.42 ± 1.02a

F3, 16 = 6.021, P = 0.006

28

123.04 ± 1.21a

132.26 ± 2.45b*

121.60 ± 1.01a

122.18 ± 1.02a

F3, 16 = 10.59, P = 0.000

r

 + 0.77

 + 0.44

 + 0.41

 
 

Time effect

F3, 16 = 1.217, P = 0.336

F3, 16 = 8.756, P = 0.001

F3, 16 = 1.714, P = 0.204

F3, 16 = 1.099, P = 0.378

 

TBIL

(mg dL−1)

7

0.67 ± 0.01a

0.68 ± 0.02a

0.66 ± 0.01a

0.69 ± 0.03a

F3, 16 = 0.554, P = 0.653

14

0.68 ± 0.01a

0.74 ± 0.04a

0.69 ± 0.04a

0.67 ± 0.03a

F3, 16 = 0.787, P = 0.519

21

0.68 ± 0.01a

0.80 ± 0.02b*

0.70 ± 0.02a

0.68 ± 0.02a

F3, 16 = 13.14, P = 0.000

28

0.69 ± 0.01a

0.83 ± 0.01b*

0.69 ± 0.02a

0.68 ± 0.03a

F3, 16 = 16.32, P = 0.000

r

 + 0.75

 + 0.27

 − 0.06

 
 

Time effect

F3, 16 = 0.764, P = 0.531

F3, 16 = 7.267, P = 0.003

F3, 16 = 0.681, P = 0.577

F3, 16 = 0.061, P = 0.98

 

IBIL

(mg dL−1)

7

0.57 ± 0.01a

0.58 ± 0.01a

0.55 ± 0.01a

0.58 ± 0.03a

F3, 16 = 0.397, P = 0.757

14

0.58 ± 0.01a

0.63 ± 0.04a

0.59 ± 0.03a

0.57 ± 0.04a

F3, 16 = 0.598, P = 0.626

21

0.58 ± 0.02a

0.69 ± 0.01b*

0.59 ± 0.01a

0.58 ± 0.01a

F3, 16 = 12.37, P = 0.000

28

0.59 ± 0.01a

0.71 ± 0.02b*

0.59 ± 0.02a

0.58 ± 0.02a

F3, 16 = 12.98, P = 0.000

r

 + 0.70

 + 0.25

 − 0.02

 
 

Time effect

F3, 16 = 0.518, P = 0.676

F3, 16 = 5.381, P = 0.009

F3, 16 = 0.694, P = 0.569

F3, 16 = 0.023, P = 0.995

 

ASAT

(U/mL)

7

34.50 ± 1.15a

35.60 ± 1.23a

34.10 ± 0.79a

33.68 ± 0.82a

F3, 16 = 0.657, P = 0.59

14

36.10 ± 0.94a

37.72 ± 1.37a

36.58 ± 1.01a

35.30 ± 1.28a

F3, 16 = 0.76, P = 0.533

21

32.60 ± 1.08a

46.32 ± 1.52b*

35.60 ± 1.30a

33.10 ± 1.12a

F3, 16 = 25.55, P = 0.000

28

34.92 ± 1.17a

55.26 ± 1.29b*

33.52 ± 1.29a

34.00 ± 1.76a

F3, 16 = 57.56, P = 0.000

r

 + 0.92

 − 0.12

 − 0.05

 
 

Time effect

F3, 16 = 1.797, P = 0.188

F3, 16 = 43.78, P = 0.000

F3, 16 = 1.558, P = 0.238

F3, 16 = 0.521, P = 0.674

 

ALAT

(U/mL)

7

25.80 ± 0.39a

25.38 ± 1.18a

25.16 ± 1.09a

25.18 ± 1.41a

F3, 16 = 0.075, P = 0.973

14

24.16 ± 0.69a

29.00 ± 2.12a

25.42 ± 1.38a

22.68 ± 1.16a

F3, 16 = 1.768, P = 0.194

21

24.76 ± 0.65a

38.28 ± 1.28b*

24.64 ± 1.42a

23.80 ± 1.37a

F3, 16 = 32.49, P = 0.000

28

25.86 ± 1.32a

41.22 ± 0.72b*

26.82 ± 1.29a

23.94 ± 1.15a

F3, 16 = 47.89, P = 0.000

r

 + 0.90

 + 0.17

 − 0.11

 
 

Time effect

F3, 16 = 0.984, P = 0.425

F3, 16 = 46.03, P = 0.000

F3, 16 = 0.512, P = 0.68

F3, 16 = 0.643, P = 0.598

 
  1. P < 0.05, P < 0.01, P < 0.000: represents significant effects. *: represent significant (P < 0.05) differences as compared to 7th day
  2. r: Pearson’s correlation coefficient of the studied parameters with the experimental time
  3. In the same row, according to Duncan’s test, means marked with the same small superscript letters are insignificantly different (P > 0.05), whereas those marked with different ones are significantly different (P < 0.05)